Daniel Efrén Rodríguez Ariza

Daniel Efrén Rodríguez Ariza

Auto-generated profile, based on publicly available information

Daniel Efrén Rodríguez Ariza

Clinical Information Management Group, Artmedica IPS, Medellín, Colombia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2024 in Lupus Science & Medicine
Verified
Journal Article
Open access
PDF file
PLPaula X Losada
Paula X Losada
LSLina Serrato
Lina Serrato
ADAna María Daza
Ana María Daza
AVAdriana Vanegas-García
Adriana Vanegas-García
CMCarlos H Muñoz
Carlos H Muñoz
GVGloria Vásquez
Gloria Vásquez
Objective This study aimed to identify the physicochemical and phenotypic characteristics of circulating Extracellular Vesicles (EVs) in the plasma of patients with SLE, with or without Lupus Nephritis (LN), and their potential utility as disease biomarkers. Methods Plasma-circulating EVs were concentrated using differential centrifugation from adult female patients (n=38) who met the ‘American College of Rheumatology/European Alliance of Associations for Rheumatology 2019’ criteria for SLE diagnosis with (LN) or without LN (nLN), confirmed by renal biopsy. Controls (n=18) were healthy volunteers matched by gender and similar age. The structure, size and Energy Dispersion Spectrum (EDS) of EVs were observed by electron microscopy. The surface charge and size distribution were evaluated using dynamic light scattering. The counts and phenotype of EVs from patients (SLE-EVs) and controls (Ctrl-EVs) were obtained using flow cytometry. Non-parametric statistical tests and exploratory analysis of multiple variables were performed. The discriminatory power of some variables as potential biomarkers of the disease was also evaluated. Results Circulating EVs were heterogeneous in morphology and size, but SLE-EVs reached larger diameters than Ctrl-EVs (p<0.0001). Small SLE-EVs and large SLE-EVs were increased compared with Ctrl-EV (p<0.0001 and p<0.05, respectively). Likewise, patients with SLE (LN or nLN) had higher concentrations of large EVs compared with controls (p<0.001 and p<0.0001, respectively). SLE-EVs showed a different EDS (p<0.001) and were less electronegative (p<0.0001) than Ctrl-EVs. EV-CD45+, EV-CD14+ and EV-IgM+ were more frequent in patients with SLE compared with controls (p<0.001, p<0.05 and p<0.001, respectively). The concentrations of large EVs and EV-IgM+ allowed better discrimination of patients from controls. Conclusions Plasma-circulating EVs from patients with SLE with and without nephritis are increased in peripheral blood and have different physicochemical properties than controls. Characteristics of EVs such as larger size and the presence of IgM on the surface could help discriminate patients from controls.

29 September 2022 in Surgery Open Science
Verified
Journal Article
Open access
ECEdward S. Cho
Edward S. Cho
MZMichael E. Zenilman
Michael E. Zenilman
PMPaul Hsin-ti McClelland
Paul Hsin-ti McClelland
DRDaniel Rodriguez
Daniel Rodriguez
JSJustin Steele
Justin Steele
MWMichael Wayne
Michael Wayne
We describe a straightforward model to implement a high volume specialty surgery program at a community hospital. Using pancreatic surgery as an example, we employed published processes in three arenas. First, mandatory multidisciplinary tumor board presentations captured all the patients considered for surgery. Then, perioperative protocols using tools such as enhanced recovery and teamwork in the perioperative arena created a reproducible and safe environment for complex surgery. We critically reviewed all complications using the Clavien-Dindo methodology, and confirmed our favorable outcomes via the targeted NSQIP program. These standard steps can be used for implementation of a new complex surgical procedure.

16 September 2021 in Revista de la Facultad de Medicina
Verified
Journal Article
Open access
PDF file
JCJuan Pablo Camargo-Mendoza
Juan Pablo Camargo-Mendoza
DADaniel Efrén Ariza-Rodríguez
Daniel Efrén Ariza-Rodríguez
Introducción. Las betalactamasas de espectro extendido (BLEE) producidas por gérmenes gram negativos se han asociado con aumento de la morbilidad y mortalidad hospitalaria, mayor estancia hospitalaria, uso de carbapenémicos y mayores costos de atención. Existen pocos trabajos que evalúen los factores de riesgo para infección por gérmenes productores de BLEE en unidades de cuidado intensivo (UCI). Objetivo. Determinar los factores de riesgo para infección asociada a la atención en salud (IAAS) por Klebsiella pneumoniae y Escherichia coli productoras de BLEE en una UCI de un hospital público de tercer nivel y evaluar el impacto de esta infección en la mortalidad. Materiales y métodos. Estudio de casos y controles con relación 1:2 (97 casos y 194 controles) realizado en pacientes en estado crítico admitidos a UCI de un hospital público de tercer nivel, en Bogotá D.C. (Colombia), entre enero de 2016 y diciembre de 2019 y en los que se documentó IAAS por K. pneumoniae y E. coli productoras de BLEE (casos) y por K. pneumoniae y E. coli con fenotipo de resistencia natural (controles). . Se realizaron análisis bivariados mediante la prueba de χ2 y U de Mann-Whitney. En el análisis multivariado se usó un modelo de regresión logística, con una prueba de dos colas con los valores p obtenidos en los análisis bivariados. Resultados. Se identificaron infecciones por K. pneumoniae y de E. coli BLEE en 57 (58,76%) y 40 (41,24%) de los casos, respectivamente. Los aislamientos se obtuvieron principalmente de muestras de orina (30.92%), seguidas de líquido peritoneal (27.83%). En el análisis multivariado, la infección de vías urinarias al ingreso a UCI fue identificada como factor de riesgo (OR=5.63; IC95%:1.918-16.53; p=0,002). La mortalidad total fue del 28.17% (26.29% en los controles y 31.95% en los casos), pero no se observó una diferencia significativa entre grupos (p=0.311). Conclusión. La infección de vías urinarias al ingreso a la UCI fue un factor de riesgo para la infección asociada a la IAAS por gérmenes productores de BLEE. Además, no se observó una diferencia significativa entre los casos y controles respecto al impacto de la infección en su mortalidad. Introducción. Las betalactamasas de espectro extendido (BLEE) producidas por gérmenes gram negativos se han asociado con aumento de la morbilidad y mortalidad hospitalaria, mayor estancia hospitalaria, uso de carbapenémicos y mayores costos de atención. Existen pocos trabajos que evalúen los factores de riesgo para infección por gérmenes productores de BLEE en unidades de cuidado intensivo (UCI). Objetivo. Determinar los factores de riesgo para infección asociada a la atención en salud (IAAS) por Klebsiella pneumoniae y Escherichia coli productoras de BLEE en una UCI de un hospital público de tercer nivel y evaluar el impacto de esta infección en la mortalidad. Materiales y métodos. Estudio de casos y controles con relación 1:2 (97 casos y 194 controles) realizado en pacientes en estado crítico admitidos a UCI de un hospital público de tercer nivel, en Bogotá D.C. (Colombia), entre enero de 2016 y diciembre de 2019 y en los que se documentó IAAS por K. pneumoniae y E. coli productoras de BLEE (casos) y por K. pneumoniae y E. coli con fenotipo de resistencia natural (controles). . Se realizaron análisis bivariados mediante la prueba de χ2 y U de Mann-Whitney. En el análisis multivariado se usó un modelo de regresión logística, con una prueba de dos colas con los valores p obtenidos en los análisis bivariados. Resultados. Se identificaron infecciones por K. pneumoniae y de E. coli BLEE en 57 (58,76%) y 40 (41,24%) de los casos, respectivamente. Los aislamientos se obtuvieron principalmente de muestras de orina (30.92%), seguidas de líquido peritoneal (27.83%). En el análisis multivariado, la infección de vías urinarias al ingreso a UCI fue identificada como factor de riesgo (OR=5.63; IC95%:1.918-16.53; p=0,002). La mortalidad total fue del 28.17% (26.29% en los controles y 31.95% en los casos), pero no se observó una diferencia significativa entre grupos (p=0.311). Conclusión. La infección de vías urinarias al ingreso a la UCI fue un factor de riesgo para la infección asociada a la IAAS por gérmenes productores de BLEE. Además, no se observó una diferencia significativa entre los casos y controles respecto al impacto de la infección en su mortalidad.

21 August 2025 in Medicina UPB
Verified
Journal Article
Open access
PDF file
DODiego Morán Ortiz
Diego Morán Ortiz
CCCamila Lema Calidonio
Camila Lema Calidonio
DADaniel Efrén Rodríguez Ariza
Daniel Efrén Rodríguez Ariza
MMMauricio Lema Medina
Mauricio Lema Medina
BFBeatriz Elena Preciado Franco
Beatriz Elena Preciado Franco
MPMauricio Luján Piedrahita
Mauricio Luján Piedrahita
Objective: To characterize patients with metastatic hormone-sensitive prostate cancer (mHSPC) treated in an outpatient oncology care institution in Medellín-Colombia.Methods: An observational, retrospective study with survival analysis. Patients with mHSPC who initiated treatment at our institution after December 2013 were included. Progression-free survival (PFS), including radiographic or serological progression, and overall survival (OS) were calculated with the Kaplan-Meier method. Subgroup analyses were carried out according to received therapy for mHSPC and tumour burden. Differences were evaluated through the log-rank test. A p-value <0.05 was considered statistically significant.Results: Data of 111 patients with mHSPC were analysed. The median follow-up was 32.2 months (IQR:15.9-47.5). The median age was 68.9 years (IQR:63.4-78.2). High tumour burden accounted for 73.9 %. The most used treatment modalities included ADT monotherapy (30.6 %), and ADT in combination with docetaxel (34.2 %). Median PFS and OS was 24.2 (95 %CI:19.0-29.5) and 53.5 months (95 % CI:45.3-61.7), respectively. In low metastatic volume patients, median PFS in the ADT monotherapy group and ADT plus other therapy group was 22.5 (CI95 %: 11.0-34.0) and 30.5 months (CI95 %:8.7-52.3), respectively (P=0.035). There was no significant difference between groups in OS.Conclusion: Comparable survival rates between our population and those described in controlled clinical trials were found.

16 July 2025 in Revista Colombiana de Reumatología
Verified
Journal Article
Closed access
SPSebastián Ospina Pérez
Sebastián Ospina Pérez
EPEvanny S. Valencia Patiño
Evanny S. Valencia Patiño
DADaniel Efrén Rodríguez Ariza
Daniel Efrén Rodríguez Ariza
JCJuan C. Díaz Coronado
Juan C. Díaz Coronado
CRCarolina Pérez Ríos
Carolina Pérez Ríos

3 November 2025 in Reumatismo
Verified
Journal Article
Open access
PDF file
DRDiana N. Rincón-Riaño
Diana N. Rincón-Riaño
DRDaniel E. Rodríguez-Ariza
Daniel E. Rodríguez-Ariza
CPCristhyan Pacheco
Cristhyan Pacheco
LGLaura J. Garcia-Ballesteros
Laura J. Garcia-Ballesteros
LGLuisa Fernanda Galindo
Luisa Fernanda Galindo
FTFabio A. Torres
Fabio A. Torres
Objective. IgG4-related disease (IgG4-RD) is a recently described fibroinflammatory disorder. The most common presentations include salivary and lacrimal gland hypertrophy, orbitary disease, autoimmune pancreatitis, retroperitoneal fibrosis, and tubulointerstitial nephritis. Lymphoplasmacytic infiltration, fibrosis, IgG4+ cell hyperplasia, and elevated IgG4 serum levels are the primary pathophysiological findings related to the disease. We describe for the first time the epidemiology and clinical manifestations in our country. Methods. A descriptive study of patients from a retrospective cohort based on clinical records of adults with IgG4-RD treated between 2014 and 2021 in a high-complexity national center. Results. 23,381 patients from 12 centers nationwide until December 2021 provided demographic data. We limited the search through ICD-10 coding: M358, M359, and M368, other specified systemic involvement of connective tissue; L948, other specified localized connective tissue disorders; D472, monoclonal gammopathy; K861, other chronic pancreatitis; H051, H059, and H063, chronic inflammatory disease of orbit; and C488, malignant neoplasm of overlapping sites of retroperitoneum and peritoneum. Thirty-three patients were identified with IgG4-RD based on comprehensive diagnostic criteria. A definitive diagnosis was obtained in 48.48% of patients, a probable diagnosis in 27.7%, and a possible diagnosis in 24.24%. A total of 21 patients were female, with a male/female (M/F) ratio of 1/1.75. The median age at diagnosis was 53.87 years (interquartile range of 27.06), the minimum age of diagnosis was 11.53 years, and the maximum was 79.18 years. Regarding clinical presentation at diagnosis, ocular/orbitary involvement was present in 16 patients (48.48%), followed by head and neck in 10 patients (30.30%), and biliary tract/gastrointestinal in 9 (27.27%). A single-organ compromise was identified in 15 patients (45.45%), and 18 patients (54.55%) had two or more organs affected, with lymphatic and ocular/orbitary being the most commonly reported. Conclusions. Epidemiologic and demographic data on IgG4-RD in our country are similar to those in the world medical literature. The higher frequency of the disease in males above 65 years and females under 65 years suggests distinct pathophysiologic factors related to sex and age. This work has a limitation of subreports or misreports, which physicians can make when registering ICD-10 codes in clinical records. Nonetheless, it is the legal record in Colombia and requires an analysis like the one made in this study.